JVMRX
Price
$25.18
Change
+$1.81 (+7.74%)
Updated
Apr 9 closing price
Net Assets
18.48B
NBREX
Price
$22.98
Change
+$1.99 (+9.48%)
Updated
Apr 9 closing price
Net Assets
42.91M
Ad is loading...

JVMRX vs NBREX

Header iconJVMRX vs NBREX Comparison
Open Charts JVMRX vs NBREXBanner chart's image
JHancock Disciplined Value Mid Cap R6
Price$25.18
Change+$1.81 (+7.74%)
VolumeN/A
Net Assets18.48B
Neuberger Berman M/C Intrinsic Val Tr
Price$22.98
Change+$1.99 (+9.48%)
VolumeN/A
Net Assets42.91M
JVMRX vs NBREX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMRX vs. NBREX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMRX is a Hold and NBREX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 18.5B vs. NBREX (42.9M). JVMRX pays higher dividends than NBREX: JVMRX (0.94) vs NBREX (0.40). JVMRX was incepted earlier than NBREX: JVMRX (14 years) vs NBREX (26 years). NBREX (1.73) is less costly to investors than JVMRX (0.76). JVMRX is a more actively managed with annual turnover of: 47.00 vs. NBREX (29.00). NBREX has a lower initial minimum investment than JVMRX: NBREX (0) vs JVMRX (1000000). JVMRX annual gain was more profitable for investors over the last year : -20.09 vs. NBREX (-21.63). NBREX return over 5 years is better than : 55.38 vs. JVMRX (39.55).
JVMRXNBREXJVMRX / NBREX
Total Expense Ratio0.751.2560%
Annual Report Gross Expense Ratio0.761.7344%
Fund Existence14 years26 years-
Gain YTD-13.252-20.16066%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets18.5B42.9M43,124%
Annual Yield % from dividends0.940.40237%
Returns for 1 year-20.09-21.6393%
Returns for 3 years-12.51-18.0569%
Returns for 5 years39.5555.3871%
Returns for 10 years16.87-10.38-162%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISBAX12.10N/A
N/A
VY® Columbia Contrarian Core A
SMERX10.45N/A
N/A
Invesco Small Cap Equity R
CBFCX34.71N/A
N/A
American Funds Global Balanced 529C
MSFLX30.53N/A
N/A
Morgan Stanley Inst Global Franchise L
TARZX20.61N/A
N/A
Third Avenue Real Estate Value Z